SGD Trademark

Trademark Overview


On Thursday, June 2, 2016, a trademark application was filed for SGD with the United States Patent and Trademark Office. The USPTO has given the SGD trademark a serial number of 79193398. The federal status of this trademark filing is PARTIAL SECTION 71 & 15 ACCEPTED AND ACKNOWLEDGED as of Wednesday, September 11, 2024. This trademark is owned by Siegfried Holding AG. The SGD trademark is filed in the Treatment & Processing of Materials Services, Chemical Products, and Pharmaceutical Products categories with the following description:

[ Treatment of materials in the nature of spry drying, milling, micronisation, nitration, hydrogenation, phosgenation, halogenation, oxidation, reduction; ] [ Custom manufacture of pharmaceutical products per customer order and in accordance with customer requirements; ] [ custom manufacture of pharmaceutical products as per customer order and in accordance with customer requirements, namely, acetal, aldehyds, alkaloids, esters, ketones, mercaptan, oxalates, acids, vitamins and ingredients used in the manufacture of medicines against cancer ]

[ Pharmaceutical, medical and veterinary preparations for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Dietetic substances and foodstuffs for medical and veterinary use, namely, antidepressant for companion animals, lice treatment; Disinfectants, preparations for destroying vermin; Fungicides, herbicides; Alkaloids for medical use; Analgesics; General anesthetics; ] Chemical preparations for medical use [ ; Chemical preparations for pharmaceutical use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood cl...

Chemical preparations for use in industry [ , science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; fertilizing preparations; fire-extinguishing compositions; tempering preparations for use in and soldering ] ; chemical substances for preserving foodstuffs [ ; tanning agents for use in the manufacture of leather, namely, oils for tanning leather; adhesives for use in industry; alkaloids for industrial purposes; Methyl and Acetic acid esters; acids ]
sgd

General Information


Serial Number79193398
Word MarkSGD
Filing DateThursday, June 2, 2016
Status708 - PARTIAL SECTION 71 & 15 ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, September 11, 2024
Registration Number5220416
Registration DateTuesday, June 13, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2017

Trademark Statements


Goods and Services[ Treatment of materials in the nature of spry drying, milling, micronisation, nitration, hydrogenation, phosgenation, halogenation, oxidation, reduction; ] [ Custom manufacture of pharmaceutical products per customer order and in accordance with customer requirements; ] [ custom manufacture of pharmaceutical products as per customer order and in accordance with customer requirements, namely, acetal, aldehyds, alkaloids, esters, ketones, mercaptan, oxalates, acids, vitamins and ingredients used in the manufacture of medicines against cancer ]
Amendment to a Registration/Renewal CertificateIn the statement, page 2, line 13 through line 50, "; Dietetic substances and foodstuffs for medical and veterinary use, namely, antidepressant for companion animals, lice treatment; Disinfectants, preparations for destroying vermin; Fungicides, herbicides; Alkaloids for medical use; Analgesics; General anesthetics; Chemical preparations for medical use; Chemical preparations for pharmaceutical use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Chemical preparations for veterinary use, namely, for antidepressant for companion animals, lice treatment; Cellulose esters for pharmaceutical use; Hormones for medical use; Potassium salts for medical use, namely, medicated bath salts; Preparations for acne treatments; Controlled substances, namely, prescription narcotics; Opiates; Pharmaceutical preparations, namely, for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Medicine, namely, sulfonamides; Veterinary preparations for treatment of depression for companion animals, lice treatment; Salts for medical use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Pharmaceutical alcohols, medicinal alcohols; Medicines for human medicines for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Medicines for veterinary use for treatment of depression for companion animals, lice treatment; Medicines for dental use for local anesthetics; Chemical-pharmaceutical preparations for injections, treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Chemical preparations for medical or veterinary use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection, treatment of depression for companion animals, lice treatment" is deleted. In the statement, page 2, line 52 through line 54, "Custom manufacture of pharmaceutical products per customer order and in accordance with customer requirements;" is deleted.
Goods and Services[ Pharmaceutical, medical and veterinary preparations for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Dietetic substances and foodstuffs for medical and veterinary use, namely, antidepressant for companion animals, lice treatment; Disinfectants, preparations for destroying vermin; Fungicides, herbicides; Alkaloids for medical use; Analgesics; General anesthetics; ] Chemical preparations for medical use [ ; Chemical preparations for pharmaceutical use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Chemical preparations for veterinary use, namely, for antidepressant for companion animals, lice treatment; Cellulose esters for pharmaceutical use; Hormones for medical use; Potassium salts for medical use, namely, medicated bath salts; Preparations for acne treatments; Controlled substances, namely, prescription narcotics; Opiates; Pharmaceutical preparations, namely, for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Medicine, namely, sulfonamides; Veterinary preparations for treatment of depression for companion animals, lice treatment; Salts for medical use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Pharmaceutical alcohols, medicinal alcohols; Medicines for human medicine for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Medicines for veterinary use for treatment of depression for companion animals, lice treatment; Medicines for dental use for local anesthetics; Chemical-pharmaceutical preparations for injections for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Chemical preparations for medical or veterinary use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection, treatment of depression for companion animals, lice treatment and veterinary preparations for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Dietetic substances and foodstuffs for medical and veterinary use, namely, antidepressant for companion animals, lice treatment; Disinfectants, preparations for destroying vermin; Fungicides, herbicides; Alkaloids for medical use; Analgesics; General anesthetics; Chemical preparations for medical use; Chemical preparations for pharmaceutical use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Chemical preparations for veterinary use, namely, for antidepressant for companion animals, lice treatment; Cellulose esters for pharmaceutical use; Hormones for medical use; Potassium salts for medical use, namely, medicated bath salts; Preparations for acne treatments; Controlled substances, namely, prescription narcotics; Opiates; Pharmaceutical preparations, namely, for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Medicine, namely, sulfonamides; Veterinary preparations for treatment of depression for companion animals, lice treatment; Salts for medical use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Pharmaceutical alcohols, medicinal alcohols; Medicines for human medicines for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Medicines for veterinary use for treatment of depression for companion animals, lice treatment; Medicines for dental use for local anesthetics; Chemical-pharmaceutical preparations for injections, treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Chemical preparations for medical or veterinary use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection, treatment of depression for companion animals, lice treatment ]
Goods and ServicesChemical preparations for use in industry [ , science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; fertilizing preparations; fire-extinguishing compositions; tempering preparations for use in and soldering ] ; chemical substances for preserving foodstuffs [ ; tanning agents for use in the manufacture of leather, namely, oils for tanning leather; adhesives for use in industry; alkaloids for industrial purposes; Methyl and Acetic acid esters; acids ]

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status CodeG - NOT AVAILABLE
Class Status DateWednesday, September 11, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, October 12, 2016
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 12, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSiegfried Holding AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressZofingen CH-4800
CH

Party NameSiegfried Holding AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressZofingen CH-4800
CH

Party NameSiegfried Holding AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressZofingen CH-4800
CH

Trademark Events


Event DateEvent Description
Friday, October 14, 2016NON-FINAL ACTION WRITTEN
Thursday, October 6, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, October 12, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 12, 2016ASSIGNED TO EXAMINER
Saturday, October 15, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 18, 2016APPLICATION FILING RECEIPT MAILED
Wednesday, November 9, 2016REFUSAL PROCESSED BY MPU
Wednesday, November 9, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, November 22, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 22, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 22, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 25, 2016REFUSAL PROCESSED BY IB
Thursday, December 8, 2016ASSIGNED TO LIE
Saturday, December 10, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 10, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 26, 2017NON-FINAL ACTION WRITTEN
Thursday, January 26, 2017NON-FINAL ACTION E-MAILED
Thursday, January 26, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 7, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 7, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, February 7, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 7, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, February 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 21, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 8, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 8, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, March 25, 2017NOTIFICATION PROCESSED BY IB
Tuesday, March 28, 2017PUBLISHED FOR OPPOSITION
Tuesday, March 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, September 13, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, September 18, 2017FINAL DISPOSITION PROCESSED
Monday, September 18, 2017FINAL DISPOSITION NOTICE SENT TO IB
Saturday, October 28, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, June 19, 2018TEAS SECTION 7 REQUEST RECEIVED
Friday, August 17, 2018AMENDMENT UNDER SECTION 7 - PROCESSED
Wednesday, April 17, 2019PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, May 8, 2019INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Thursday, July 30, 2020NEW REPRESENTATIVE AT IB RECEIVED
Monday, June 13, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, November 5, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 23, 2023NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 3, 2023TEAS SECTION 71 & 15 RECEIVED
Monday, July 9, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 9, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 11, 2024REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Monday, May 12, 2025PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, September 1, 2025INVALIDATION PROCESSED
Wednesday, September 11, 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Saturday, September 27, 2025PARTIAL INVALIDATION PROCESSED BY THE IB
Tuesday, September 2, 2025INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Monday, September 1, 2025PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB